Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kala Bio Q3 EPS $(1.07) Beats $(1.45) Estimate

Author: Benzinga Newsdesk | November 19, 2025 10:16am
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.45) by 25.95 percent. This is a 44.56 percent increase over losses of $(1.93) per share from the same period last year.

Posted In: KALA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist